CerenomeCNSY

13F holders, Q2 2026 (June 30)
22holders +21
19new positions
0sold out
1famous investor
$4.37avg. 13F price*

At the end of Q2 2026, 22 institutions reported holding Cerenome Inc. (CNSY) in their 13F filings, up 21 from Q1 2026. 19 opened new positions and 0 sold out. The largest holders were Vanguard Capital Management LLC ($1.3M), BlackRock, Inc. ($419K) and Geode Capital Management, LLC ($333K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Cerenome Inc.
Filed as
PLUS THERAPEUTICS INC (Q2 2026)
CUSIP
72941H806
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q1 2026: 1Q1 2026Q2 2026: 22Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions19$2.9M
Exits0$0

All 13F filers, Q1 2026 → Q2 2026: 660,151 shares bought and 2,393 shares sold, net +657,758 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 22 holders

Vanguard Capital Management LLC 0.00% New 304,745 $1.3M
BlackRock, Inc. 0.00% New 95,983 $419K
Geode Capital Management, LLC 0.00% New 76,155 $333K
Vanguard Fiduciary Trust Co. 0.00% New 36,868 $161K
Ashton Thomas Private Wealth, LLC 0.00% New 34,306 $150K
State Street Corp. 0.00% New 30,853 $135K
Citadel Advisors 0.00% New 25,597 $112K
Northern Trust Corp. 0.00% New 15,516 $68K
Virtu Financial LLC 0.00% New 15,343 $67K
HRT Financial LP 0.00% New 11,612 $50K
Wells Fargo & Company 0.00% New 6,156 $27K
Vanguard Global Advisers, LLC 0.00% New 2,282 $10K
Osaic Holdings, Inc. 0.00% New 2,000 $9K
Tower Research Capital LLC (TRC) 0.00% New 1,955 $9K
UBS Group AG 0.00% New 470 $2K
Allied Private Wealth LLC 0.00% — 496 $2K
SBI Securities Co., Ltd. 0.00% Reduce -90.5% 251 $1K
Morgan Stanley 0.00% New 185 $808
Barclays PLC 0.00% New 96 $420
Citigroup Inc. 0.00% New 17 $74
Caitong International Asset Management Co., Ltd 0.00% New 12 $52
Global Retirement Partners, LLC 0.00% — 4 $17

"% of holder's portfolio" is CNSY's weight in each manager's 13F, not the share of Cerenome Inc. the manager owns.